Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C, Marinò M, Vaidya B, Wiersinga WM (2021) The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur J Endocrinol 185(4):G43-g67. https://doi.org/10.1530/eje-21-0479
Bartalena L, Fatourechi V (2014) Extrathyroidal manifestations of Graves’ disease: a 2014 update. J Endocrinol Invest 37(8):691–700. https://doi.org/10.1007/s40618-014-0097-2
Ponto KA, Merkesdal S, Hommel G, Pitz S, Pfeiffer N, Kahaly GJ (2013) Public health relevance of Graves’ orbitopathy. J Clin Endocrinol Metab 98(1):145–152. https://doi.org/10.1210/jc.2012-3119
Wiersinga WM (2012) Quality of life in Graves’ ophthalmopathy. Best Pract Res Clin Endocrinol Metab 26(3):359–370. https://doi.org/10.1016/j.beem.2011.11.001
Ponto KA, Pitz S, Pfeiffer N, Hommel G, Weber MM, Kahaly GJ (2009) Quality of life and occupational disability in endocrine orbitopathy. Dtsch Arztebl Int 106(17):283–289. https://doi.org/10.3238/arztebl.2009.0283
Article PubMed PubMed Central Google Scholar
Luo Yao-Sheng SJ (2023) Interpretation of 2022 Chinese Guidelines for Diagnosis and Management of Thyroid Associated Ophthalmopathy:diagnosis and medical treatment. Chinese J Pract Int Med 43(11):890–892+897. https://doi.org/10.19538/j.nk2023110103
Javeed N, Matveyenko AV (2018) Circadian Etiology of Type 2 Diabetes Mellitus. Physiology (Bethesda) 33(2):138–150. https://doi.org/10.1152/physiol.00003.2018
Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ (2022) Type 2 diabetes. Lancet 400(10365):1803–1820. https://doi.org/10.1016/s0140-6736(22)01655-5
Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF (2010) Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 8:29. https://doi.org/10.1186/1478-7954-8-29
Article PubMed PubMed Central Google Scholar
Chatterjee S, Khunti K, Davies MJ (2017) Type 2 diabetes. Lancet 389(10085):2239–2251. https://doi.org/10.1016/s0140-6736(17)30058-2
Kalmann R, Mourits MP (1999) Diabetes mellitus: a risk factor in patients with Graves’ orbitopathy. Br J Ophthalmol 83(4):463–465. https://doi.org/10.1136/bjo.83.4.463
Article PubMed PubMed Central Google Scholar
Ramamurthy LB, Rangarajan V, Srirao N, Malini B, Bansal R, Yuvarajan K (2020) Severity of thyroid eye disease and type-2 diabetes mellitus: Is there a correlation? Indian J Ophthalmol 68(6):1127–1131. https://doi.org/10.4103/ijo.IJO_1443_19
Article PubMed PubMed Central Google Scholar
Rath S, Pattnaik M, Tripathy D, Mohapatra S, Panigrahy B, Ali MH (2021) Sight-Threatening Thyroid Eye Disease: Role of Diabetes Mellitus and Interaction with Other Risk Factors. Ophthalmic Plast Reconstr Surg 37(4):352–360. https://doi.org/10.1097/iop.0000000000001871
Patel VK, Padnick-Silver L, D’Souza S, Bhattacharya RK, Francis-Sedlak M, Holt RJ (2022) Characteristics of Diabetic and Nondiabetic Patients With Thyroid Eye Disease in the United States: A Claims-Based Analysis. Endocr Pract 28(2):159–164. https://doi.org/10.1016/j.eprac.2021.11.080
Smith TJ, Hegedüs L (2016) Graves’ Disease. N Engl J Med 375(16):1552–1565. https://doi.org/10.1056/NEJMra1510030
Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11(2):98–107. https://doi.org/10.1038/nri2925
Biondi B, Kahaly GJ, Robertson RP (2019) Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders. Endocr Rev 40(3):789–824. https://doi.org/10.1210/er.2018-00163
Article PubMed PubMed Central Google Scholar
Zhu L, Jiang X (2024) Characteristics of blood lipid and metabolic indicators in subclinical hypothyroidism patients: a retrospective study. Front Med (Lausanne) 11:1439626. https://doi.org/10.3389/fmed.2024.1439626
Pavan Kumar J, Um A (2024) Comparison of Thyroid Function Tests Among Type 2 Diabetes Patients With and Without Diabetic Nephropathy and Controls. Cureus 16(9):e70462. https://doi.org/10.7759/cureus.70462
Article PubMed PubMed Central Google Scholar
Hadgu R, Worede A, Ambachew S (2024) Prevalence of thyroid dysfunction and associated factors among adult type 2 diabetes mellitus patients, 2000–2022: a systematic review and meta-analysis. Syst Rev 13(1):119. https://doi.org/10.1186/s13643-024-02527-y
Article PubMed PubMed Central Google Scholar
Bartalena L, Piantanida E, Gallo D, Lai A, Tanda ML (2020) Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy. Front Endocrinol (Lausanne) 11:615993. https://doi.org/10.3389/fendo.2020.615993
Le Moli R, Muscia V, Tumminia A, Frittitta L, Buscema M, Palermo F, Sciacca L, Squatrito S, Vigneri R (2015) Type 2 diabetic patients with Graves’ disease have more frequent and severe Graves’ orbitopathy. Nutr Metab Cardiovasc Dis 25(5):452–457. https://doi.org/10.1016/j.numecd.2015.01.003
Hanru Z (2008) Case analysis and Treatment of Hyperthyroidism with Diabetes. China Foreign Med Treat 33:40. https://doi.org/10.16662/j.cnki.1674-0742.2008.33.070
Jiandong T, Longtao L, Zhiqiang K, Qingming L (2012) Clinical analysis of thyroid dysfunction in Type 2 diabetic patients. Modern Med J China 14(02):56–58
Del Bosque-Plata L, Amin M, Gragnoli C (2022) PSMD9 is linked to T2D age of onset, years of isolated and combined insulin therapy, irregular menses, and hot flashes. Eur Rev Med Pharmacol Sci 26(23):8873–8878. https://doi.org/10.26355/eurrev_202212_30559
Jie H, Pengfei Y (2023) Clinical study on three indicators of thyroid function in patients with type 2 diabetes mellitus complicated with Graves’ disease. Chinese J Control Endem Dis 38(03):255–256
Zhang Y, Wang Y, Liu M, Wei L, Huang J, Dong Z, Guan M, Wu W, Gao J, Huang X, Guo X, Xie P (2023) The value of FT4/TSH ratio in the differential diagnosis of Graves’ disease and subacute thyroiditis. Front Endocrinol (Lausanne) 14:1148174. https://doi.org/10.3389/fendo.2023.1148174
Mele C, Mai S, Cena T, Pagano L, Scacchi M, Biondi B, Aimaretti G, Marzullo P (2022) The pattern of TSH and fT4 levels across different BMI ranges in a large cohort of euthyroid patients with obesity. Front Endocrinol (Lausanne) 13:1029376. https://doi.org/10.3389/fendo.2022.1029376
Pirahanchi Y, Toro F, Jialal I (2025) Physiology, Thyroid Stimulating Hormone. In: StatPearls. StatPearls Publishing Copyright © 2025, StatPearls Publishing LLC., Treasure Island (FL) ineligible companies. Disclosure: Fadi Toro declares no relevant financial relationships with ineligible companies. Disclosure: Ishwarlal Jialal declares no relevant financial relationships with ineligible companies
Allam MA, Nassar YA, Shabana HS, Mostafa S, Khalil F, Zidan H, Abo-Ghebsha M, Abdelghaffar A, Essmat A, Elmahdi E (2021) Prevalence and Clinical Significance of Subclinical Hypothyroidism in Diabetic Peripheral Neuropathy. Int J Gen Med 14:7755–7761. https://doi.org/10.2147/ijgm.S337779
Article PubMed PubMed Central Google Scholar
Yazdanpanah S, Rabiee M, Tahriri M, Abdolrahim M, Rajab A, Jazayeri HE, Tayebi L (2017) Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review. Crit Rev Clin Lab Sci 54(4):219–232. https://doi.org/10.1080/10408363.2017.1299684
Reynolds TM, Smellie WS, Twomey PJ (2006) Glycated haemoglobin (HbA1c) monitoring. BMJ 333(7568):586–588. https://doi.org/10.1136/bmj.38947.627847.AE
Comments (0)